A chip-based assay for botulinum neurotoxin A activity in pharmaceutical preparations

scientific article published on 12 February 2015

A chip-based assay for botulinum neurotoxin A activity in pharmaceutical preparations is …

scholarly article

External links are

P2093	author name string	Oussama El Far
		Géraldine Ferracci
		Christian Lévêque
		Michael Seagar
		Chloé Grand-Masson
		Yves Maulet
P2860	cites work	Chip devices for miniaturized biotechnology	Q36287953
		Clinical uses of botulinum neurotoxins: current indications, limitations and future developments	Q36395728
		Clinical applications of botulinum toxin	Q38024438
		Botulinum neurotoxins: genetic, structural and mechanistic insights.	Q38224215
		Recombinant SNAP-25 is an effective substrate for Clostridium botulinum type A toxin endopeptidase activity in vitro	Q38341971
		Characterization of SNARE cleavage products generated by formulated botulinum neurotoxin type-a drug products	Q42724012
		A substrate sensor chip to assay the enzymatic activity of Botulinum neurotoxin A.	Q43999920
		Direct biosensor detection of botulinum neurotoxin endopeptidase activity in sera from patients with type A botulism.	Q51520805
		Botulinum toxin therapy: its use for neurological disorders of the autonomic nervous system.	Q54458418
P433	issue	10
P407	language of work or name	English	Q1860
P304	page(s)	4355-4360
P577	publication date	2015-02-12
P1433	published in	Applied Microbiology and Biotechnology	Q13553694
P1476	title	A chip-based assay for botulinum neurotoxin A activity in pharmaceutical preparations
P478	volume	99

cites work (P2860)

Q61795736	Content/Potency Assessment of Botulinum Neurotoxin Type-A by Validated Liquid Chromatography Methods and Bioassays
Q64087153	Functional detection of botulinum neurotoxin serotypes A to F by monoclonal neoepitope-specific antibodies and suspension array technology
Q90721192	Optimization of SNAP-25 and VAMP-2 Cleavage by Botulinum Neurotoxin Serotypes A-F Employing Taguchi Design-of-Experiments